Open AccessAssociation of T315I mutation with resistance to tyrosine kinase inhibitor therapy in patients with CML attended the Oncology-Hematology center in Al-Najaf city of Iraq
Author(s) -
Rahem Mahdy Rahem,
Adel Abdulhussien Abuhmood,
Luwaa Hussein
Publication year - 2017
Publication title -
karbala international journal of modern science
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.345
H-Index - 17
eISSN - 2405-6103
pISSN - 2405-609X
DOI - 10.1016/j.kijoms.2017.08.004
Subject(s) - medicine , dasatinib , imatinib , hematology , guideline , nilotinib , tyrosine kinase , oncology , myeloid leukemia , pathology , receptor